Beam Therapeutics Inc. (BEAM)
Nasdaq • BEAM • US07373V1052
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 29.4% of free float sold short, 15.2 days to cover, cost to borrow 0.5%. Sign up for live short interest data.
Market Cap
2.69b USD | # 3456 in US
Volume
1.85m shares | 48.44m USD
Shares Outstanding
99.67m
Free Float Shares
88.37% | 88.07m
